UBS has described the UK equity market as an "incomplete plate rather than an empty one" in its latest monthly strategy note, concluding that disciplined stock selection rather than broad index exposure is the right approach.
The bank's REVS framework, which assesses regime, earnings, valuation and sentiment across a two to six month tactical horizon, assigns the UK market a fragile score, one notch below constructive, with earnings now the strongest supportive pillar and sentiment the most significant drag.
The FTSE 100's purchasing managers' index (PMI) new orders cycle has moved from slowdown back into recovery, with the pharmaceuticals sector the most positive contributor to the latest shift, but UBS characterises the sequence as rotation rather than expansion.
The FTSE 250 is more problematic: it has rallied around 6% and sits only about 1% below its February peak, but its PMI regime has slipped into a downturn, with real estate the primary negative contributor.
On earnings, both 2026 and 2027 earnings-per-share forecasts have been revised higher again, with energy moving from laggard to the primary driver of market-cap-weighted earnings growth, a shift UBS says tightens the link between the energy shock, commodity exposure, and index delivery.
Valuations remain cheap but are described as a cushion rather than a catalyst, with UK equities still trading at a structural discount to Europe and smaller and mid-sized companies bearing the domestic risk premium most acutely.
Sentiment has eased from stressed to neutral, with options markets now in what UBS calls a conditional calm zone.
But the bank flags persistent structural crowding as the key constraint, noting the effective number of stocks driving UK returns remains the clearest evidence that concentration is structural rather than cyclical.
Crowded expensive positions in consumer discretionary, health care and industrials are highlighted as particularly vulnerable.
UBS's trade ideas favour cash-generative companies with visible dividends and buyback yields, inflation-resilient sectors including energy, materials and financials, and selectively valued smaller and mid-sized companies with strong free cash flow and low leverage.
On the macro backdrop, UBS forecasts UK GDP growth of 1% in 2026, slowing sharply from a strong first quarter, with higher energy prices expected to weigh on activity through the remainder of the year.
Inflation is forecast to average 3.1% in 2026 and the bank now expects the Bank of England's next rate cut to come in early 2027, with the policy rate currently at 3.75%.
Among the highest-ranked UK stocks on the REVS framework are GSK PLC (LSE:GSK, NYSE:GSK), Renishaw PLC (LSE:RSW) and Spirax Group PLC (LSE:SPX); the lowest-ranked include Diageo PLC (LSE:DGE), Dunelm Group PLC (LSE:DNLM) and Bellway PLC (LSE:BWY).
